Weihua Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 10%
Papers in
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 3
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 9
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Fang Hao (2 shared papers)Fan Li (3 shared papers)Yang Qu (1 shared paper)Lihua Jia (1 shared paper)Hai Li (1 shared paper)Ingrid Y. Liu (1 shared paper)Robert L. Cook (2 shared papers)Robert M. Strongin (2 shared papers)
- Journals
- Scientific Reports (1 paper)Frontiers in bioscience (1 paper)Nature Communications (1 paper)Current topics in behavioral neurosciences (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Weihua Wang
38 papers receiving 1.0k citations
Weihua Wang's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 303
- Molecular Medicine 52
- Molecular Biology 591
- Cell Biology 135
- Immunology 174
Countries citing papers authored by Weihua Wang
This map shows the geographic impact of Weihua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Wang more than expected).
Fields of papers citing papers by Weihua Wang
This network shows the impact of papers produced by Weihua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Wang. The network helps show where Weihua Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weihua Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer Hit paper breakdown → | 2022 | 163 |
| 2 | 2017 | 75 | |
| 3 | 2015 | 69 | |
| 4 | 2013 | 66 | |
| 5 | 2006 | 64 | |
| 6 | 2004 | 64 | |
| 7 | 2006 | 56 | |
| 8 | 2013 | 51 | |
| 9 | 2004 | 47 | |
| 10 | 2018 | 40 | |
| 11 | 2020 | 38 | |
| 12 | 2016 | 29 | |
| 13 | 2015 | 25 | |
| 14 | 2007 | 24 | |
| 15 | 2019 | 21 | |
| 16 | 2017 | 20 | |
| 17 | 2021 | 20 | |
| 18 | 2012 | 18 | |
| 19 | 2022 | 17 | |
| 20 | 2006 | 16 |
About Weihua Wang
Weihua Wang is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Genetics and Organic Chemistry, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers), Nerve injury and regeneration (3 papers), Microtubule and mitosis dynamics (3 papers), RNA modifications and cancer (3 papers), Boron and Carbon Nanomaterials Research (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (303 citations), Molecular Medicine (52 citations), Molecular Biology (591 citations), Cell Biology (135 citations) and Immunology (174 citations). Weihua Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Fang Hao, Fan Li, Yang Qu, Lihua Jia, Hai Li, Ingrid Y. Liu, Robert L. Cook, Robert M. Strongin, Hans‐Jörg Schneider and Jorge O. Escobedo. Their work appears in journals such as Scientific Reports, Frontiers in bioscience, Nature Communications, Current topics in behavioral neurosciences and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.